The Evolution of Innovation Incentives: IRC § 41 (2014) and the Massachusetts Research and Development Tax Credit

Internal Revenue Code Section 41, as of January 1, 2014, provides a federal tax credit for increasing research activities, utilizing an “Alternative Method” to simplify calculations by referencing a three-year spending baseline rather than complex historical data. In Massachusetts, this federal framework is integrated into the state corporate excise through M.G.L. c. 63, § 38M, allowing local businesses to leverage federal definitions of qualified research to secure state-level credits for activities conducted within the Commonwealth.

The research and development (R&D) tax credit serves as a vital fiscal instrument for fostering technological advancement, high-value employment, and economic competitiveness. At the federal level, this incentive is governed by Internal Revenue Code (IRC) § 41, a provision that has transitioned from a temporary “tax extender” to a permanent fixture of the American tax landscape.1 For Massachusetts-based corporations, the state-level credit provided by M.G.L. c. 63, § 38M, represents a sophisticated adaptation of federal law, tailored to the specific economic needs of a state heavily reliant on the life sciences, software, and defense sectors.3 The year 2014 was a pivotal moment in this legislative history, as it marked both a period of federal retroactive restoration and the enactment of landmark state legislation that modernized the Massachusetts credit by adopting the federal Alternative Simplified Credit (ASC) methodology.1

The Statutory Meaning of IRC § 41 as of January 1, 2014

To understand the meaning of IRC § 41 on January 1, 2014, one must first navigate the legislative paradox that defined that date. On the first day of 2014, the federal research credit had technically expired, having reached its sunset provision at midnight on December 31, 2013.1 However, the Internal Revenue Code “as in effect” on that date refers to the body of law that was subsequently retroactively restored by the Tax Increase Prevention Act of 2014 (TIPA), signed into law in December 2014.1 Consequently, the “meaning” of the law for that period encompasses the full suite of definitions and calculation methods—including the Alternative Simplified Credit—that taxpayers relied upon to incentivize over $14.3 billion in research expenditures over the following decade.8

The Structural Components of the Federal Research Credit

The federal credit under Section 41 is not a singular benefit but rather the sum of several distinct components.10 For the 2014 tax year, the total credit was equal to the sum of:

1. Twenty percent of the excess of qualified research expenses (QREs) for the year over a defined base amount.10
2. Twenty percent of basic research payments determined under subsection (e)(1)(A), which generally relate to payments made to universities and certain scientific research organizations.10
3. Twenty percent of amounts paid or incurred to an energy research consortium.10

The “Alternative Method” requested by taxpayers usually refers to the Alternative Simplified Credit (ASC) codified in IRC § 41(c)(5), which allows for an election to bypass the cumbersome “Regular Research Credit” calculation.11

Qualified Research and the Four-Part Test

Central to the meaning of IRC § 41 is the rigorous definition of “Qualified Research.” For an activity to generate credits, it must satisfy a cumulative four-part test designed to separate routine business development from genuine technological innovation.16

Research that satisfies these requirements qualifies for the credit, provided it does not fall into excluded categories such as research conducted after commercial production, adaptation of existing business components, or research in the social sciences, arts, or humanities.11

Categories of Qualified Research Expenses (QREs)

The “Alternative Method” applies its rate to Qualified Research Expenses, which the Code divides into “in-house” and “contract” expenses.4 In-house research expenses encompass wages paid to employees for qualified services, supplies used in the conduct of research (excluding land and depreciable property), and amounts paid for the right to use computers in the conduct of qualified research.4 Contract research expenses generally include 65 percent of any amount paid to a person other than an employee for qualified research.11 However, if the contract research is performed by a qualified research consortium, the eligible portion increases to 75 percent.8

The Alternative Simplified Credit (ASC) under IRC § 41(c)(5)

The ASC method, which was the predominant “Alternative Method” in effect on January 1, 2014, was introduced to alleviate the significant documentation burdens associated with the traditional Regular Research Credit (RRC).14 The RRC requires a “fixed-base percentage” that often depends on a company’s financial data from 1984 through 1988—records that many mature corporations no longer possess and that startups must navigate through complex “start-up rules”.12

Calculation Methodology of the ASC

The ASC calculation is inherently more straightforward than the regular method because it ignores gross receipts and focuses solely on the taxpayer’s recent history of research spending.15 For a taxpayer making the election, the credit is equal to 14 percent of the amount by which the current year’s QREs exceed 50 percent of the average QREs for the three taxable years preceding the credit year.10

If a taxpayer did not have QREs in each of the three preceding taxable years, a special rule under Section 41(c)(5)(B) applies, setting the credit at 6 percent of the current year’s QREs.10 This provides a lower, yet still accessible, incentive for businesses just beginning their research efforts or those re-entering the R&D space after a hiatus.14

Election and Revocation Dynamics

An election to use the ASC must be made on a timely filed original return (including extensions).14 Once the election is made, it remains in effect for all subsequent taxable years unless the taxpayer obtains the consent of the Secretary to revoke it.10 On January 1, 2014, Treasury regulations were also in transition regarding the ability to elect the ASC on an amended return.25 Shortly thereafter, TD 9666 provided a long-overdue modification, allowing taxpayers to elect the ASC on an amended return provided they had not previously claimed a Section 41 credit for that year using a different method.25 This change was a critical development for companies that failed to identify their R&D eligibility during the initial filing process.25

Massachusetts Context: M.G.L. c. 63, § 38M and the 2014 Pivot

Massachusetts has historically incentivized innovation through a state-level credit that “closely parallels” the federal credit.18 However, for many years, the Massachusetts credit was tethered to a static version of the IRC—specifically the version in effect on August 12, 1991.18 This created a “conformity gap” where state law did not recognize federal improvements like the ASC until much later.22

The Impact of the 2014 Economic Development Act

The Massachusetts landscape shifted dramatically with the passage of St. 2014, c. 287 (An Act Promoting Economic Growth Across the Commonwealth) and its companion technical corrections in St. 2014, c. 359.6 This legislation modernized the state’s R&D tax credit in two significant ways:

1. It revised the “Regular Method” by updating the definitions of “base amount” and “fixed-base ratio” to decouple them from the 1980s data, moving instead to a rolling lookback period based on the third and fourth years preceding the credit year.6
2. It introduced an “Alternative Simplified Method” for Massachusetts, explicitly modeled after the federal ASC under IRC § 41(c)(5) as in effect on January 1, 2014.3

This state-level ASC was made available for tax years beginning on or after January 1, 2015, but it was anchored to the federal law as it stood on January 1, 2014.3

The Seven-Year Phase-In of the Massachusetts ASC

While the federal ASC rate was fixed at 14 percent, the Massachusetts legislature enacted a phased-in rate for the state version of the simplified credit to manage the fiscal impact on the Commonwealth’s budget.3

For taxpayers without QREs in any of the three preceding years, the Massachusetts ASC is set at a flat 5 percent of current year QREs.3 This structure ensures that even new innovators in the Commonwealth receive a baseline incentive.22

Local State Revenue Office Guidance and Application

The Massachusetts Department of Revenue (DOR) provided essential interpretive guidance through Technical Information Releases (TIRs) and regulations that explain how the new law applies to corporate taxpayers.

TIR 14-13: The Modernization Overview

TIR 14-13 was the primary vehicle for explaining the 2014 changes.6 It clarified that business corporations could now elect to calculate their research credit using one of two methods.6 The first method modernized the existing 10 percent credit by changing the definitions of “base amount” and “fixed-base rate” to reference more recent data.6 The second method introduced the Alternative Simplified Method, which “generally conforms to the methodology of the federal alternative simplified credit provided by I.R.C. § 41(c)(5), as amended and in effect for January 1, 2014”.6

The TIR also emphasized that for both methods, the definition of what constitutes a “qualified research expense” remains tied to the underlying federal definitions, ensuring consistency between state and federal claims.6 However, the state credit remains strictly limited to expenditures incurred for research activity conducted within Massachusetts.3

TIR 14-16: Addressing the Legislative Omission

TIR 14-16, issued in response to a supplemental budget act, provided a “technical correction” to a drafting error in the original 2014 Economic Development Act.6 The original law had inadvertently omitted the requirement that the credit be calculated based on the excess over 50 percent of the three-year average for the middle phase-in years (2018–2020).6 TIR 14-16 confirmed that the corrected law requires the 50 percent threshold to be applied across all years, maintaining the structural integrity of the incremental credit.7

Regulation 830 CMR 63.38M.2

The detailed mechanics of the post-2015 credit are found in Regulation 830 CMR 63.38M.2.20 This regulation provides several critical rules for taxpayers:

• Accounting Methods: In determining when a research expense is incurred, a corporation must use the same method of accounting it uses for the federal credit under § 41.20
• Massachusetts-Only Rule: Wages are qualified only if they are paid for services performed in Massachusetts; supplies must be consumed in Massachusetts; and computer fees must relate to computers located in the state.20
• Contract Research: Only 65 percent of contract research expenses are included, and they must be attributable to research activity conducted at a research facility located in Massachusetts.20

The regulation also details how to handle aggregated groups of corporations, a necessary provision since many innovation-heavy companies operate through multiple subsidiaries.20

Utilization Limits and the “Indefinite Carryforward”

One of the most nuanced aspects of the Massachusetts R&D credit is how it interacts with a corporation’s tax liability. Unlike the federal credit, which is generally subject to broader general business credit limitations, the Massachusetts credit has specific statutory caps and unique carryforward rules.3

The $25,000 Threshold and the 75% Rule

Under M.G.L. c. 63, § 38M, a corporation’s research credit use is restricted in two stages 3:

1. The First Bracket: 100 percent of the corporation’s first $25,000 of excise liability may be offset by the credit.3
2. The Excess Bracket: Only 75 percent of the corporation’s excise liability in excess of $25,000 may be offset by the credit.3

This means that for a corporation with a large tax bill, the R&D credit can never completely eliminate its liability.4 Additionally, the credit cannot reduce the excise below the minimum tax of $456.4

The Two Tiers of Carryforwards

Massachusetts provides a distinct “safety valve” for credits that cannot be used due to these limitations.3

• 15-Year Carryover: Credits that exceed the total tax liability (after the 75 percent rule and minimum tax are applied) can be carried forward for 15 years.3
• Indefinite Carryover: Credits that were disallowed specifically because of the 75 percent rule may be carried forward indefinitely.4

This indefinite carryforward is particularly valuable for large tech and life science firms that consistently generate more credits than the 75 percent rule allows them to use.4 It ensures that the incentive is never truly lost, even if its realization is deferred.4

Comparative State Analysis: Massachusetts vs. Other Jurisdictions

Massachusetts is part of a competitive landscape of states offering research incentives. While the IRC § 41 definitions are largely standard, the application of the ASC method varies significantly between states, affecting where businesses choose to locate their R&D hubs.26

Comparison of ASC Conformity and Rates (2014-2015 Era)

This data illustrates that Massachusetts’ adoption of the ASC method, especially at the eventual 10 percent rate, positioned it as one of the more aggressive and taxpayer-friendly jurisdictions for R&D.32 By offering a phased-in approach, the Commonwealth signaled a long-term commitment to innovation while managing short-term fiscal volatility.4

Industry-Specific Provisions: Life Sciences and Defense

Massachusetts has tailored its R&D credit to bolster its competitive advantage in specific high-growth sectors. These provisions often interact with federal law in unique ways.

Life Sciences Refundability

While the standard Massachusetts research credit is non-refundable, certified life sciences companies through the Massachusetts Life Sciences Center (MLSC) can access a special refund provision.4 These companies may request a refund of up to 90 percent of the value of unused research credits.4 This is a massive strategic advantage for pre-revenue biotech firms, allowing them to monetize their tax credits to fund ongoing clinical trials and laboratory work.4

Defense-Related Activities

M.G.L. c. 63, § 38M includes a specialized calculation for defense-related activities, which includes researching arms, ammunition, and implements of war.3 In 2014, the definition of defense research was expanded to include medical supplies and biologics designed to treat diseases related to chemical, biological, or nuclear threats.21 Corporations can elect to calculate the credit separately for these activities, ensuring that shifts in their commercial research do not dilute the credits earned on essential defense contracts.21

Case Study: Applying the ASC Methodology (Comprehensive Example)

To bridge the gap between theory and practice, consider the following example of a Massachusetts-based software engineering firm, “Quantum Solutions Inc.,” which elects to use the Alternative Simplified Method in 2015.

Step 1: Data Collection

Quantum Solutions Inc. identifies the following Massachusetts-only QREs 4:

• 2015 (Credit Year): $2,500,000
• 2014 (Prior Year 1): $2,000,000
• 2013 (Prior Year 2): $1,800,000
• 2012 (Prior Year 3): $1,600,000

The company also determines its 2015 Massachusetts Corporate Excise liability is $350,000.21

Step 2: Calculate the ASC Base Amount

The base is 50 percent of the average QREs for the three preceding years.4

$$Average = \frac{2,000,000 + 1,800,000 + 1,600,000}{3} = 1,800,000$$

$$Base = 1,800,000 \times 0.50 = 900,000$$

Step 3: Calculate the State Credit

The 2015 Massachusetts ASC rate is 5 percent.6

$$Incremental QRE = 2,500,000 – 900,000 = 1,600,000$$

$$MA Credit = 1,600,000 \times 0.05 = 80,000$$

Step 4: Apply Excise Limitations

The credit must be applied against the $350,000 liability.3

• 100% Offset (First $25k): $25,000 of the credit is used to offset the first $25,000 of excise.
• 75% Offset (Excess over $25k): The remaining excise is $325,000 ($350,000 – $25,000).
• Max Additional Offset: $325,000 \times 0.75 = 243,750$.
• Credit Remaining: $80,000 – 25,000 = 55,000$.

Since the remaining credit ($55,000) is less than the maximum additional offset allowed ($243,750), the company can use the entire $80,000 credit in 2015.21

Final Result

• Final Excise Due: $350,000 – 80,000 = 270,000$.
• Federal Comparison: Under IRC § 41, the federal credit (at 14 percent) would have been $224,000 on the same incremental basis ($1,600,000 x 0.14).15 By stacking these credits, the company significantly lowers its effective tax rate.4

Compliance and Regulatory Oversight

For any taxpayer claiming the research credit, particularly under the “Alternative Method,” maintaining meticulous records is the primary defense against an audit.17

IRS Audit Techniques and the “Shrink-Back” Rule

The IRS Audit Techniques Guide provides insight into how examiners view research claims.17 One key concept is the “Shrink-back” rule, which dictates that the requirements of Section 41 must be applied first at the level of the discrete business component (e.g., the specific product or process being developed).17 If the entire product fails the four-part test, the taxpayer must “shrink back” the claim to the most discrete sub-component that does meet the criteria.17 This requires a granular level of project tracking that many businesses find challenging.17

Business Component Identification

Taxpayers are required to tie every dollar of claimed QRE to a specific business component.17 This involves identifying the specific individuals who performed the research, the uncertainty they sought to eliminate, and the experimental process they followed.37 Failure to maintain these records can lead to a summary rejection of the claim during an examination.37

Economic Impact and Future Outlook

The 2014-2015 period was a time of significant fiscal activity in Massachusetts. In FY 2015, the state saw a 5.8 percent revenue increase, driven largely by higher-than-expected income tax payments.38 This surplus allowed for the certification of over $1.3 billion in community aid and the administration of tax amnesty programs that brought in over $87 million across two campaigns.38

In this environment of fiscal health, the R&D tax credit was positioned as a permanent, rather than temporary, incentive—a major point of contrast with the federal credit, which was still stuck in a cycle of yearly extensions as of January 1, 2014.1 This stability has made Massachusetts an attractive destination for R&D-centric firms.4

Conclusion

The meaning of IRC § 41 as in effect on January 1, 2014, is fundamentally defined by the transition toward simplicity via the Alternative Simplified Credit. While the federal credit was plagued by legislative uncertainty at that time, its core definitions remained the bedrock upon which states like Massachusetts built their own innovation economies. The pivot of 2014—where Massachusetts adopted the federal ASC methodology—represented a critical modernization of the Commonwealth’s tax code, removing the “lookback” barriers that had previously prevented many companies from accessing the credit.

For business corporations, the interaction between the federal “Alternative Method” and the Massachusetts state credit offers a powerful dual-incentive. However, the path to a successful claim requires a deep understanding of the local state revenue office guidance, including the phased-in rates of TIR 14-13 and the technical corrections of TIR 14-16. By carefully documenting research activities at the “business component” level and navigating the unique 75 percent excise limitation, Massachusetts firms can effectively leverage these tax tools to sustain their competitive edge in the global innovation market. The lasting legacy of the 2014 reforms is a tax regime that values recent innovation over historical data, ensuring that the Commonwealth remains a leading hub for the technologies of tomorrow.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/